Orbital Involvement in Multiple Myeloma: A Case Report


Purpose: To report a retro-orbital localization of Multiple Myeloma (MM) describing its treatment and clinical result. Case report: A 50-years-old male patient with Magnetic Resonance Imaging (MRI) evidence of a retro-orbital mass with exophthalmos, due to the pathological diagnosis of MM, was referred for Radiation Therapy (RT). Discussion: The orbital involvement in Multiple Myeloma is rare and few cases are reported in the literature. The treatment of choice is RT alone with a prescribed dose ranging between 40 Gy and 45 Gy. In our patient the retro-orbital lesion, measuring 26 × 16 mm, was treated with Intensity Modulated Radiotherapy Technique (IMRT) delivering 4400 cGy with conventional fractionation. The treatment was well tolerated, the patient experienced a complete regression of the exophthalmos without any significant side effect.

Share and Cite:

S. Terenzi, D. Cristino, A. Murgia, D. Janniello, E. Ponti, B. Tolu, S. Cicchetti and R. Santoni, "Orbital Involvement in Multiple Myeloma: A Case Report," Journal of Cancer Therapy, Vol. 3 No. 6, 2012, pp. 1052-1054. doi: 10.4236/jct.2012.36136.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] M. Castro-Rebollo, R. Canones-Zafra, E. N. VlemingPinilla, P. Drake-Rodriguez-Casanova and C. Pérez-Rico, “Unilateral Exophthalmos as the Debut of a Non-Secretory Multiple Myeloma,” Archivos de la Sociedad Espanola de Oftalmologia, Vol. 84, No. 12, 2009, pp. 631-634. doi:10.4321/S0365-66912009001200008
[2] A. Sharma, M. Kaushal, N. K. Chaturvedi and R. Yadav, “Cytodiagnosis of Multiple Myeloma Presenting as Orbital Involvement: A Case Report,” CytoJournal, Vol. 10, 2006, pp. 3-19.
[3] A. J. Knapp, S. Gartner and P. Henkind, “Multiple Myeloma and Its Ocular Manifestations,” Survey of Ophthalmology, Vol. 31, 1987, pp. 343-351. doi:10.1016/0039-6257(87)90119-6
[4] H. L. Rodman and R. L. Font, “Orbital Involvement in Multiplemyeloma: A Review of Literature and Report of Three Cases,” Archives of Ophthalmology, Vol. 87, 1972, pp. 30-35. doi:10.1001/archopht.1972.01000020032006
[5] C. N. Burkat, J. J. Van Buren and M. J. Lucarelli, “Characteristics Of Orbital Multiple Myeloma: A Case Report And Literature Review,” Survey of Ophthalmology, Vol. 54, No. 6, 2009, pp. 697-704.
[6] J. Y. Chu, A. J. Lewis and D. H. Cowan, “IgDK Multiple Myeloma Presenting as Unilateral Proptosis,” Canadian Journal of Neurological Sciences, Vol. 12, No. 1, 1985, pp. 69-72.
[7] E. Clarke, “Plasma cell Myeloma of the Orbit,” British Journal of Ophthalmology, Vol. 37, No. 9, 1953, pp. 543-554. doi:10.1136/bjo.37.9.543
[8] P. Greenberg, R. G. Parker, Y. Fu and E. Abemayor, “The Treatment of Solitary Plasmacytoma of Bone and Extramedullaryplasmacytoma,” American Journal of Clinical Oncology, Vol. 10, No. 3, 1987, pp. 199-204. doi:10.1097/00000421-198706000-00004
[9] A. Di Marzo, G. Parca, G. Ingrosso, C. Giubilei, M. Battista, M. Benassi, et al., “Retro-Orbitalgranulocytic Sarcoma: Case Report,” Tumori, Vol. 94, No. 6, 2008, pp. 869-872.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.